Latest Versant Venture Management, LLC Stock Portfolio

About Versant Venture Management, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $86.7 Millions as of 31 Dec, 2024.

The top stock holdings of Versant Venture Management, LLC are GLUE, CRSP, . The fund has invested 45.2% of it's portfolio in MONTE ROSA THERAPEUTICS, INC. and 22.6% of portfolio in CRISPR THERAPEUTICS AG.

The fund managers got completely rid off GRITSTONE ONCOLOGY, INC. (GRTS) stocks. Versant Venture Management, LLC opened new stock positions in MONTE ROSA THERAPEUTICS, INC. (GLUE) and TEMPEST THERAPEUTICS, INC. (TPST).

Versant Venture Management, LLC Annual Return Estimates Vs S&P 500

New Buys

Ticker	$ Bought
monte rosa therapeutics, inc.	39,231,300
tempest therapeutics, inc.	2,926,640

New stocks bought by Versant Venture Management, LLC

Additions

No additions were made to existing positions by Versant Venture Management, LLC

Reductions

None of the existing positions were reduced by Versant Venture Management, LLC

Sold off

Ticker	$ Sold
gritstone oncology, inc.	-2,065,110

Versant Venture Management, LLC got rid off the above stocks

Sector Distribution

Sector	%
Healthcare	77.9
Others	22.1

Market Cap. Distribution

Category	%
MICRO-CAP	51.9
MID-CAP	22.6
UNALLOCATED	22.1
NANO-CAP	3.4

Stocks belong to which Index?

Index	%
Others	54.8
RUSSELL 2000	45.2

Top 5 Winners (%)		%

Top 5 Winners ($)		$

Top 5 Losers (%)		%
RPTX	repare therapeutics, inc.	-61.9 %
ADVM	adverum biotechnologies, inc.	-33.5 %
CRSP	crispr therapeutics ag	-16.2 %
TPST	tempest therapeutics, inc.	-8.8 %
GLUE	monte rosa therapeutics, inc.	-8.2 %

Top 5 Losers ($)		$
RPTX	repare therapeutics, inc.	-5.6 M
CRSP	crispr therapeutics ag	-3.8 M
GLUE	monte rosa therapeutics, inc.	-3.5 M
ADVM	adverum biotechnologies, inc.	-1.2 M
TPST	tempest therapeutics, inc.	-0.3 M

Versant Venture Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Versant Venture Management, LLC

Last Reported on: 12 Feb, 2025

	Ticker	Namesorted descending	% Portfolio	Shares Held	$ Value	Type	% Change
	GLUE	monte rosa therapeutics, inc.	45.22	5,652,920	39,231,300	new
Historical Trend of MONTE ROSA THERAPEUTICS, INC. Position Held By Versant Venture Management, LLC What % of Portfolio is GLUE?: Number of GLUE shares held: Change in No. of Shares Held:
	CRSP	crispr therapeutics ag	22.62	498,558	19,623,200	unchanged	0.00

		contineum therapeutics, inc.	15.51	918,163	13,451,100	unchanged	0.00

	SKYE	skye bioscience, inc.	6.55	2,007,700	5,681,800	unchanged	0.00

	RPTX	repare therapeutics, inc.	4.00	2,646,660	3,467,120	unchanged	0.00

	TPST	tempest therapeutics, inc.	3.37	3,507,060	2,926,640	new

	ADVM	adverum biotechnologies, inc.	2.73	506,821	2,366,850	unchanged	0.00

	GRTS	gritstone oncology, inc.	0.00	0.00	0.00	sold off	-100